News, Events & Insights

PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies – New Laboratory Technology Emerges from PHC Group Synergy –

Events
29 Apr 2025

Visit us at 2025 PDA Pharmaceutical Manufacturing & Quality Conference!

SciMed and STERIS will be participating in the upcoming 2025 PDA Pharmaceutical Manufacturing Quality Conference. As one of our valued customers, we would be delighted to have you join us at this event. Event Details Date : 6th to 7th May 2025 Time : 8 AM to 6 PM Venue : Andaz Singapore, by Hyatt […]

Read More

News
04 Sep 2024

PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies – New Laboratory Technology Emerges from PHC Group Synergy –

Left: Controller (MLC-AC0-P*) / Right: Detector (MLC-AD240A-P*) Bottom: Sensor module (MLC-AS240A-PW) PHC Corporation’s Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic(*1) changes in cell cultures, providing a more complete picture of cell activity for research […]

News
14 Jun 2024

SciMed (Asia) – First Anniversary as wholly owned subsidiary of PHC Holdings Corporation

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has

News
15 Jun 2023

SciMed (Asia), Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation, Becomes Wholly Owned Subsidiary — Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific —

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has